Timely Second-Dose Completion of mRNA COVID-19 Vaccination at Community-Based and Mobile Vaccine Clinics in Maryland

Am J Public Health. 2023 Sep;113(9):947-951. doi: 10.2105/AJPH.2023.307338. Epub 2023 Jul 6.

Abstract

To assess factors associated with timely second-dose completion, we analyzed COVID-19 vaccine data from community-based and mobile vaccine clinics in Maryland. Overall, 85.3% of patients received a timely second dose. Factors associated with a timely second dose included Latino ethnicity (adjusted odds ratio [AOR] = 1.5; 95% confidence interval [CI] = 1.1, 2.0) and receipt of the first dose at community-based vaccine clinics (AOR = 2.1; 95% CI = 1.8, 2.5). Future health initiatives for underserved communities should focus on establishing vaccine clinics in trusted community spaces with culturally sensitive support. (Am J Public Health. 2023;113(9):947-951. https://doi.org/10.2105/AJPH.2023.307338).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Community Health Centers
  • Female
  • Humans
  • Male
  • Maryland / epidemiology
  • Middle Aged
  • Mobile Health Units
  • Pandemics
  • Young Adult
  • mRNA Vaccines* / administration & dosage
  • mRNA Vaccines* / adverse effects

Substances

  • COVID-19 Vaccines
  • mRNA Vaccines